Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neurocrine Bioscience buy Royal Bank of Canada

Neurocrine Bioscience
Start price
€83.38
14.04.25 / 50%
Target price
€120.31
14.04.26
Performance (%)
31.63%
End price
€109.75
15.04.26
Summary
This prediction ended on 15.04.26 with a price of €109.75. The BUY prediction by Royal_Bank_of_Canada for Neurocrine Bioscience saw massive gains of 31.63%. Royal_Bank_of_Canada has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Neurocrine Bioscience -1.951% -1.951% 16.791%
iShares Core DAX® -1.059% 5.007% 6.596%
iShares Nasdaq 100 -2.387% 0.864% 25.791%
iShares Nikkei 225® -4.361% 1.211% 41.309%
iShares S&P 500 -1.778% 1.391% 21.037%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) 31.63%
Target price 120.313
Change
Ends at 14.04.26

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $137.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat

Royal Bank of Canada 
0
Report Share
14.04.25
In the thread Trading Neurocrine Bioscience
Prediction Buy
Perf. (%) 31.63%
Target price 120.313
Change
Ends at 14.04.26

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Royal Bank of Canada 
0
Report Share
15.04.26

Current prediction by Royal_Bank_of_Canada for Neurocrine Bioscience

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€123.05
05.09.25
€127.74
05.09.26
8.25%
19.08.26

Royal Bank of Canada 
05.09.25 50%

Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€144.65
31.07.26
€172.02
31.07.27
-7.92%
19.08.26

Royal Bank of Canada 
31.07.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€155.00
07.07.26
€170.49
07.07.27
-14.06%
19.08.26

Royal Bank of Canada 
07.07.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€135.75
29.05.26
€157.23
29.05.27
-1.88%
19.08.26

Royal Bank of Canada 
29.05.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€123.15
06.05.26
€153.58
06.05.27
8.16%
19.08.26

Royal Bank of Canada 
06.05.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€105.60
12.02.26
€149.00
12.02.27
26.14%
19.08.26

Royal Bank of Canada 
12.02.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€137.35
08.12.25
€154.48
08.12.26
-3.02%
19.08.26

Royal Bank of Canada 
08.12.25 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€117.85
29.10.25
€137.36
29.10.26
13.03%
19.08.26

Royal Bank of Canada 
29.10.25 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€112.45
31.07.25
€125.97
31.07.26
28.01%
01.08.26

Royal Bank of Canada 
31.07.25 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€108.85
02.06.25
€127.53
02.06.26
21.08%
03.06.26

Royal Bank of Canada 
02.06.25 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€105.90
06.05.25
€128.38
06.05.26
17.00%
07.05.26

Royal Bank of Canada 
06.05.25 50%